EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Molecular Screening Reveals De Novo Loss-of-Function NR4A2 Variants in Saudi Children with Autism Spectrum Disorders: A Single-Center Study

Najwa M Alharbi, Wejdan F Baaboud, Heba Shawky iD, Aisha A Alrofaidi iD, Reem M Farsi iD, Khloud M Algothmi, Shahira A Hassoubah, Fatemah S Basingab iD, Sheren A Azhari, Mona G Alharbi, Reham Yahya iD, Safiah Alhazmi iD

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26125468 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Najwa M Alharbi und 11 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Science, Department of Biological Sciences, King Abdul-Aziz University, Jeddah 21589, Saudi Arabia. Hauptthemen laut MEDLINE: Autism Spectrum Disorder, Nuclear Receptor Subfamily 4, Group A, Member 2, Loss of Function Mutation. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: King Faisal Specialist Hospital & Research Center, King Faisal Specialist Hospital & Research Center.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Dysregulated expression of nuclear receptor superfamily 4 group A member 2 (NR4A2) has recently been associated with autistic spectrum disorder (ASD), speech impairment, and neurodevelopmental delay (NDD); however, its precise role in the prevalence and etiopathogenesis of ASD has not been fully elucidated. Herein, we aimed to explore the role of NR4A2 variants in the genetic underpinnings of ASD among Saudi children of different age ranges and phenotype severities. A total of 338 children with ASD from 315 unrelated families (293 simplex, 2 quads, and 1 quintet) were screened for NR4A2 variants via exome sequencing (ES) of the genomic DNA extracted from peripheral blood mononuclear cells (PBMCs), after which the probands with identified NR4A2 variants were further subjected to trio genetic analyses. ES analysis revealed 10 de novo NR4A2 variants (5 indels/nonsense, 2 missense, and 3 variants affecting splicing) in 8 unrelated probands (2.37%) and 2 affected siblings from 8 unrelated families (6 simplex (2.04%) and 2 quads (8.7%)). Three NR4A2 variants were notably recurrent among both affected and unaffected carriers. All identified indels and two splicing variants met the criteria for pathogenic/loss-of-function (LoF) variants according to the ACMG classification (PVS1), whereas the missense variants were classified as of uncertain significance (VUS). This study is among the first to identify such a high frequency of recurrent variants in an ASD cohort, suggesting their significant contribution to the etiopathogenesis of ASD within this population.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Autism Spectrum DisorderNuclear Receptor Subfamily 4, Group A, Member 2Loss of Function MutationHumansMaleSaudi ArabiaFemaleChildChild, PreschoolGenetic Predisposition to DiseaseExome SequencingPhenotypeAdolescent

Stichwörter der Autor:innen

ASDNR4A2developmental disordersrecurrent variantsspeech impairment

Substanzen

Nuclear Receptor Subfamily 4, Group A, Member 2NR4A2 protein, human

Autor:innen und Institutionen

  • Faculty of Science, Department of Biological Sciences, King Abdul-Aziz University, Jeddah 21589, Saudi Arabia.
  • Therapeutic Chemistry Department, Pharmaceutical Industries and Drug Research Institute, National Research Centre, Dokki, Cairo 12622, Egypt.
  • Immunology Unit, King Fahad Medical Research Center, King Abdul-Aziz University, Jeddah 21589, Saudi Arabia.
  • Department of Medical Microbiology, College of Science and Health Professions, King Saud Bin Abdul-Aziz University for Health Sciences, Riyadh 14611, Saudi Arabia.
  • King Abdullah International Medical Research Center, Riyadh 11481, Saudi Arabia.
  • Neuroscience and Geroscience Research Unit, King Fahd Medical Research Centre, King Abdul-Aziz University, Jeddah 80200, Saudi Arabia.

ORCID-Profile: Heba Shawky, Aisha A Alrofaidi, Reem M Farsi, Fatemah S Basingab, Reham Yahya, Safiah Alhazmi

Förderung

  • King Faisal Specialist Hospital & Research Center
  • King Faisal Specialist Hospital & Research Center

Zitieren

APA

Alharbi, N. M., Baaboud, W. F., Shawky, H., Alrofaidi, A. A., Farsi, R. M., Algothmi, K. M., Hassoubah, S. A., Basingab, F. S., Azhari, S. A., Alharbi, M. G., Yahya, R., & Alhazmi, S. (2025). Molecular Screening Reveals De Novo Loss-of-Function NR4A2 Variants in Saudi Children with Autism Spectrum Disorders: A Single-Center Study. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26125468

Vancouver

Alharbi NM, Baaboud WF, Shawky H, Alrofaidi AA, Farsi RM, Algothmi KM, et al. Molecular Screening Reveals De Novo Loss-of-Function NR4A2 Variants in Saudi Children with Autism Spectrum Disorders: A Single-Center Study. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26125468

BibTeX
@article{Alharbi2025,
  author = {Alharbi, Najwa M and Baaboud, Wejdan F and Shawky, Heba and Alrofaidi, Aisha A and Farsi, Reem M and Algothmi, Khloud M and Hassoubah, Shahira A and Basingab, Fatemah S and Azhari, Sheren A and Alharbi, Mona G and Yahya, Reham and Alhazmi, Safiah},
  title = {Molecular Screening Reveals De Novo Loss-of-Function NR4A2 Variants in Saudi Children with Autism Spectrum Disorders: A Single-Center Study},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26125468}
}
Kostenlos starten →